Analysts expect Lexicon Pharmaceuticals, Inc. to report revenue of 4.34 M for Q3 26, against a range of 3.97 M to 4.72 M. The most recent reported quarter, Q2 26, came in at 692,000.00, a 81.9% miss against the 3.83 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1.75 M | 26.55 M | 1.26 M | 28.87 M | 14.18 M | 5.49 M | 21.10 M | 692,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 3.03 M | 7.18 M | 1.42 M | 5.52 M | 5.05 M | 3.46 M | 9.67 M | 4.16 M | 4.72 M | 12.71 M | 597,990.36 | 715,228.05 | 5.94 M | 14.99 M | 5.37 M | 8.76 M | ||||||||||
| Low Estimate | 2.68 M | 6.48 M | 1.23 M | 4.63 M | 4.61 M | 3.20 M | 8.54 M | 3.50 M | 3.97 M | 11.13 M | 538,713.52 | 598,909.77 | 5.16 M | 12.57 M | 4.42 M | 8.08 M | ||||||||||
| Consensus Estimate | 2.85 M | 6.83 M | 1.32 M | 5.08 M | 4.83 M | 3.33 M | 9.10 M | 3.83 M | 4.34 M | 11.92 M | 568,351.94 | 657,068.91 | 5.55 M | 13.78 M | 4.89 M | 8.42 M |
Analysts expect Lexicon Pharmaceuticals, Inc. to report earnings per share of -0.06 for Q3 26, against a range of -0.06 to -0.06. The most recent reported quarter, Q2 26, came in at -0.07, a 40.0% miss against the -0.05 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.18 | -0.09 | -0.07 | 0.01 | -0.04 | -0.04 | 0.00 | -0.07 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.14 | -0.11 | -0.09 | -0.06 | -0.07 | -0.07 | -0.03 | -0.05 | -0.06 | -0.03 | -0.06 | -0.06 | -0.06 | -0.02 | -0.03 | -0.04 | ||||||||||
| Low Estimate | -0.16 | -0.13 | -0.11 | -0.08 | -0.07 | -0.07 | -0.03 | -0.05 | -0.06 | -0.03 | -0.06 | -0.06 | -0.06 | -0.02 | -0.03 | -0.04 | ||||||||||
| Consensus Estimate | -0.15 | -0.12 | -0.10 | -0.07 | -0.07 | -0.07 | -0.03 | -0.05 | -0.06 | -0.03 | -0.06 | -0.06 | -0.06 | -0.02 | -0.03 | -0.04 |
Pull Wall Street consensus for Lexicon Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=LXRX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "LXRX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=LXRX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();